Exozymes (EXOZ) Total Non-Current Liabilities (2023 - 2024)
Exozymes (EXOZ) has disclosed Total Non-Current Liabilities for 2 consecutive years, with $6.2 million as the latest value for Q3 2024.
- Quarterly Total Non-Current Liabilities changed N/A to $6.2 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $6.2 million through Sep 2024, changed N/A year-over-year, with the annual reading at $2.9 million for FY2023, N/A changed from the prior year.
- Total Non-Current Liabilities for Q3 2024 was $6.2 million at Exozymes, up from $2.9 million in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $6.2 million in Q3 2024, with the low at $2.9 million in Q4 2023.